STOCKWATCH
·
Medical Specialities
Quarterly ResultApr 29, 2026, 06:13 AM

HUM Q1 GAAP EPS $9.83, Adj. EPS $10.31; FY26 GAAP EPS Revised

AI Summary

Humana Inc. reported Q1 2026 GAAP EPS of $9.83 and Adjusted EPS of $10.31, meeting the high end of its guidance. The company affirmed its FY 2026 Adjusted EPS guidance of "at least $9.00" but revised its GAAP EPS guidance to "at least $8.36" from "at least $8.89". The Insurance segment's GAAP benefit ratio was 89.4%, slightly favorable to guidance. Humana also confirmed the retirement of George Renaudin, Insurance Segment President, effective June 29, 2026, with Aaron Martin and John Barger assuming new leadership roles.

Key Highlights

  • George Renaudin, Insurance Segment President, to retire June 29, 2026; Aaron Martin and John Barger to assume new leadership roles.
  • 1Q26 GAAP EPS reported at $9.83; Adjusted EPS at $10.31, at the high end of company guidance.
  • FY26 Adjusted EPS guidance affirmed at "at least $9.00".
  • FY26 GAAP EPS guidance revised to "at least $8.36" from the previous estimate of "at least $8.89".
  • 1Q26 Insurance segment GAAP benefit ratio was 89.4%, slightly favorable to management's guidance.
  • Affirmed FY26 individual Medicare Advantage (MA) membership growth of approximately 25% over 2025.
  • CenterWell Senior Primary Care saw sequential growth of 110,500 patients, including 59,000 from the MaxHealth acquisition.
  • 1Q26 state-based contracts membership grew by approximately 50,000, driven by new programs.
HUM
Medical Specialities
HUMANA INC

Price Impact